Barrett Esophagus Recurrence After Complete Endoscopic Eradication with Radiofrequency Ablation

Dysplastic Barrett esophagus is a lifelong condition that requires regular endoscopic surveillance for recurrence.

Recent guidelines recommend radiofrequency ablation (RFA) as the primary treatment for Barrett esophagus (BE) with high-grade dysplasia and the preferred treatment for BE with low-grade dysplasia (LGD; Am J Gastroenterol 2016; 111:30). Recent best-practice recommendations suggest that, after complete endoscopic eradication of LGD, endoscopic surveillance should be performed with four-quadrant biopsy annually for 2 years and then every 3 years continuously (NEJM JW Gastroenterol Dec 2016 and Gastroenterology 2016; 151:822).

In a retrospective single-center cohort study, investigators reviewed records of 218 patients who received RFA for dysplastic BE until complete eradication of intestinal metaplasia. Subsequent endoscopic surveillance was p…

Reviewing Author

David A. Johnson, MD

Disclosures

Consultant/Advisory boardMedscape/WebMD; Pfizer; CRH Medical Corporation; Aries

EquityCRH Medical Corporation

Editorial boardsMedscape Gastroenterology

Leadership positions in professional societiesAmerican College of Gastroenterology Research Institute Board of Directors